Registry of Lobbyists

Registration - Consultant

Innovative Medicines Canada / Médicaments novateurs Canada / ANDRE ALBINATI, Consultant

Registration Information

Client name: Innovative Medicines Canada / Médicaments novateurs Canada
Previous client names
Lobbyist name: ANDRE ALBINATI, Consultant
Initial registration start date: 2003-02-28
Registration status: Inactive
Registration Number: 775866-2182

Associated Communications

Total Number of Communication Reports: 41

Monthly communication reports in the last 6 months: 0

Version 8 of 25 (2008-05-22 to 2008-08-12)

Version 8 of 25 (2008-05-22 to 2008-08-12) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Registrant

Consultant lobbyist name: ANDRE ALBINATI    Lobbyist business address
Consulting firm: EARNSCLIFFE STRATEGY GROUP
Suite 200, 46 Elgin Street
OTTAWA, ON  K1P 5K6
Canada
Position: PRINICPAL
Telephone number: 613-563-4455  
Fax number: 613-236-6173  
 
Former public office holder: Yes
Payment is contingent on the success of the undertaking: No

B. Information about Client

Client: Canada's Research -Based Pharmaceutical Companies Rx&D
1220-55 Metcalfe St.
Ottawa, ON  K1P 6L5
Canada
Telephone number: 613-236-0455
Fax number: 613-236-7919  
 
Client Representative: Russell Williams
 
Parent: The client is not a subsidiary of any other parent companies.
Coalition: The client is not a coalition.
Subsidiary: The client does not have any subsidiaries that could be affected by the outcome of the undertaking.
Individual, organization or corporation: The client's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Aboriginal Affairs and Northern Development Canada, Agriculture and Agri-Food Canada (AAFC), Atlantic Canada Opportunities Agency (ACOA), Atomic Energy Control Board (AECB), Canadian International Development Agency (CIDA), Canadian International Trade Tribunal (CITT), Citizenship and Immigration Canada, Environment Canada, Federal Office of Regional Development – Quebec (FORD[Q]), Finance Canada (FIN), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Human Resources Development Canada (HRDC), Industry Canada, Justice Canada (JC), Members of the House of Commons, National Defence (DND), National Research Council (NRC), Natural Resources Canada (NRCan), Natural Sciences and Engineering Research Council (NSERC), Office of the Information and Privacy Commissioner (OIPC), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Works and Government Services Canada, Revenue Canada (RC), Science & Technology Innovation Council of Canada, Senate of Canada, Solicitor General Canada (SGC), Transport Canada (TC), Treasury Board Of Canada Secretariat (TBS), Veterans Affairs Canada (VAC), Western Economic Diversification Canada (WD)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Aboriginal Affairs, Consumer Issues, Defence, Education, Employment and Training, Environment, Fisheries, Forestry, Health, Industry, Infrastructure, Intellectual Property, Internal Trade, International Relations, International Trade, Justice and Law Enforcement, Regional Development, Science and Technology, Small Business, Taxation and Finance
 

Details Regarding the Identified Subject Matter

Categories Description
Policy or Program Advice & support in relation to science and technology policy
Legislative Proposal Budget/budget update
Bill or Resolution C-51 An Act to amend the Food and Drugs Act and to make consequential amendments to other Acts
Regulation Food and drug Regulations
Policy or Program National Pharmaceutical Strategy
Regulation Patented Medicines (Notice of compliance) Regulations
Policy or Program Policies and submissions relating to counterfeiting.

Government institutions added through a communication report: Chief Government Whip View



Date Modified: